Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4934543 | Psychoneuroendocrinology | 2017 | 30 Pages |
Abstract
These data suggest that higher circulating DHEA(S) levels (while unmedicated and after eight weeks of SSRI treatment) predict SSRI-associated remission in MDD. This raises the possibility that endogenous DHEA(S) abundance is a physiological adjunct to SSRI efficacy, as suggested by prior preclinical and clinical studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Christina M. Hough, Daniel Lindqvist, Elissa S. Epel, Molly St. Denis, Victor I. Reus, F. Saverio Bersani, Rebecca Rosser, Laura Mahan, Heather M. Burke, Owen M. Wolkowitz, Synthia H. Mellon,